Lexaria Bioscience Corp. | Balance Sheet
Fiscal year is September-August. All values USD Thousands.
2012
2013
2015
2016
2017
2018
Cash & Short Term Investments
180.50
65.50
260.10
93.40
2,533.30
1,737.30
Total Accounts Receivable
290.90
79.20
31.40
131.10
45.30
265.80
Inventories
-
-
168.00
134.70
67.20
87.20
Other Current Assets
1.50
1.50
215.30
151.00
149.70
193.70
Total Current Assets
472.90
146.30
674.70
510.20
2,795.50
2,284.10
Net Property, Plant & Equipment
3,718.80
3,427.10
-
2.50
1.90
1.20
Intangible Assets
-
-
37.00
54.00
62.80
146.50
Total Assets
4,191.80
3,573.40
711.70
566.60
2,860.20
2,431.80
ST Debt & Current Portion LT Debt
1,642.50
1,277.20
-
331.40
42.70
Accounts Payable
67.00
136.30
33.10
90.00
32.60
Other Current Liabilities
1.80
1.80
22.10
12.50
17.10
Total Current Liabilities
1,711.30
1,415.20
55.10
433.90
92.30
Long-Term Debt
-
-
-
45.00
-
Other Liabilities
59.20
59.20
-
-
-
Total Liabilities
1,770.60
1,474.40
55.10
478.90
92.30
Common Equity (Total)
2,421.20
2,098.90
772.40
266.00
3,006.30
Total Shareholders' Equity
2,421.20
2,098.90
772.40
266.00
3,006.30
Total Equity
2,421.20
2,098.90
656.60
87.80
2,767.80
Liabilities & Shareholders' Equity
4,191.80
3,573.40
711.70
566.60
2,860.20
Accumulated Minority Interest
-
-
115.80
178.30
238.50
About Lexaria Bioscience
View Profile
